Trials / Completed
CompletedNCT01401985
A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)
A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects With Opioid-Induced Constipation
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 95 (actual)
- Sponsor
- Theravance Biopharma · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects with Opioid-Induced Constipation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TD-1211 | Capsules |
| DRUG | Placebo | Capsules |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2012-05-01
- Completion
- 2012-08-01
- First posted
- 2011-07-26
- Last updated
- 2021-05-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01401985. Inclusion in this directory is not an endorsement.